Brian Baranick
EVP, GM, Precision Oncology · EXACT SCIENCES CORP
- 2024
- Mar 23, 2026
- 6
Summary
Latest filing:
Brian Baranick is EVP, GM, Precision Oncology of EXACT SCIENCES CORP (EXAS). 6 SEC Form 4 filings on record going back to 2024, most recently on 23 March 2026. Most recent open-market trade: sold $200K of EXAS on 6 November 2025. Lifetime open-market sales: $265K.
Recent transactions
20The latest 20 SEC Form 4 transactions reported by Brian Baranick.
Trading pattern
InsiderAlpha's records for Brian Baranick go back to 2024: 6 primary Form 4 filings, an average of 2.0 per year. 2 recorded transactions carry a Rule 10b5-1 plan flag. This identifies the marked transactions as reported under a trading plan; it does not establish the plan status of unmarked transactions.
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Brian Baranick files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Katherine S. Zanotti - $780K in EXAS purchases and sales in the last 12 months
- Jacob A. Orville - $375K in EXAS purchases and sales in the last 12 months
- James Herriott - $175K in EXAS purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Brian Baranick?
Brian Baranick is a corporate insider, tracked as EVP, GM, Precision Oncology of EXACT SCIENCES CORP (EXAS). InsiderAlpha holds 6 primary Form 4 filings for them, the earliest from 2024, updated as new SEC EDGAR filings are processed.
When did Brian Baranick last file a Form 4?
The most recent primary Form 4 on record is dated 23 March 2026, one of 6 filings going back to 2024.
Has Brian Baranick been buying or selling stock?
Recorded transactions: 0 open-market purchases and 2 open-market sales ($265K) across all tracked filings.